MENU
component-ddb-728x90-v1-01-desktop

FDA approves new drug for migraine sufferers

This May 10, 2018, image provided by Amgen Inc. shows an artist’s rendering of the packaging for the drug Aimovig, the first in a new class of long-acting drugs designed to prevent chronic migraines. On Thursday, May 17, 2018, the Food and Drug Administration approved the medication, clearing the monthly shot for sale. (Amgen Inc. via AP)

close video ad
Unmutetoggle ad audio on off

Trending